nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—thyroid cancer	0.665	1	CbGaD
Pioglitazone—CYP2C8—Sorafenib—thyroid cancer	0.0328	0.205	CbGbCtD
Pioglitazone—CYP2C19—Sorafenib—thyroid cancer	0.0275	0.172	CbGbCtD
Pioglitazone—CYP2C9—Sorafenib—thyroid cancer	0.0229	0.143	CbGbCtD
Pioglitazone—CYP3A4—Vandetanib—thyroid cancer	0.0221	0.138	CbGbCtD
Pioglitazone—CYP2D6—Sorafenib—thyroid cancer	0.0209	0.131	CbGbCtD
Pioglitazone—CYP3A4—Sorafenib—thyroid cancer	0.0133	0.083	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—thyroid cancer	0.0127	0.0792	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—thyroid cancer	0.00807	0.0504	CbGbCtD
Pioglitazone—Rosiglitazone—PPARG—thyroid cancer	0.00363	1	CrCbGaD
Pioglitazone—Ischaemia—Sorafenib—thyroid cancer	0.00344	0.0247	CcSEcCtD
Pioglitazone—Visual acuity reduced—Vandetanib—thyroid cancer	0.00313	0.0224	CcSEcCtD
Pioglitazone—Polyp—Vandetanib—thyroid cancer	0.00306	0.0219	CcSEcCtD
Pioglitazone—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0028	0.0883	CbGpPWpGaD
Pioglitazone—Cyst—Vandetanib—thyroid cancer	0.00278	0.02	CcSEcCtD
Pioglitazone—Transient ischaemic attack—Sorafenib—thyroid cancer	0.00249	0.0178	CcSEcCtD
Pioglitazone—Proteinuria—Vandetanib—thyroid cancer	0.00212	0.0152	CcSEcCtD
Pioglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.0021	0.0663	CbGpPWpGaD
Pioglitazone—Protein urine present—Vandetanib—thyroid cancer	0.00209	0.015	CcSEcCtD
Pioglitazone—Neoplasm—Vandetanib—thyroid cancer	0.00168	0.0121	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00156	0.0112	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00156	0.0491	CbGpPWpGaD
Pioglitazone—Gastroenteritis—Vandetanib—thyroid cancer	0.00152	0.0109	CcSEcCtD
Pioglitazone—Proteinuria—Sorafenib—thyroid cancer	0.00143	0.0102	CcSEcCtD
Pioglitazone—Protein urine present—Sorafenib—thyroid cancer	0.00141	0.0101	CcSEcCtD
Pioglitazone—Hypoglycaemia—Vandetanib—thyroid cancer	0.00138	0.00992	CcSEcCtD
Pioglitazone—Cardiac failure—Vandetanib—thyroid cancer	0.00138	0.00992	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00119	0.00854	CcSEcCtD
Pioglitazone—Influenza—Vandetanib—thyroid cancer	0.00117	0.00837	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptors—THRB—thyroid cancer	0.00115	0.0362	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00114	0.0361	CbGpPWpGaD
Pioglitazone—SLCO1B3—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00114	0.036	CbGpPWpGaD
Pioglitazone—Neoplasm—Sorafenib—thyroid cancer	0.00113	0.00814	CcSEcCtD
Pioglitazone—Bronchitis—Vandetanib—thyroid cancer	0.00112	0.00805	CcSEcCtD
Pioglitazone—Tooth abscess—Epirubicin—thyroid cancer	0.00111	0.00796	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00108	0.00778	CcSEcCtD
Pioglitazone—Weight decreased—Vandetanib—thyroid cancer	0.00106	0.00757	CcSEcCtD
Pioglitazone—Hyperglycaemia—Vandetanib—thyroid cancer	0.00105	0.00755	CcSEcCtD
Pioglitazone—Infestation NOS—Vandetanib—thyroid cancer	0.00104	0.00746	CcSEcCtD
Pioglitazone—Infestation—Vandetanib—thyroid cancer	0.00104	0.00746	CcSEcCtD
Pioglitazone—Tooth abscess—Doxorubicin—thyroid cancer	0.00103	0.00737	CcSEcCtD
Pioglitazone—Hepatic failure—Sorafenib—thyroid cancer	0.00101	0.00727	CcSEcCtD
Pioglitazone—Urinary tract infection—Vandetanib—thyroid cancer	0.00101	0.00725	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Sorafenib—thyroid cancer	0.001	0.0072	CcSEcCtD
Pioglitazone—Haematuria—Vandetanib—thyroid cancer	0.000992	0.00712	CcSEcCtD
Pioglitazone—Sinusitis—Vandetanib—thyroid cancer	0.000976	0.007	CcSEcCtD
Pioglitazone—Cardiac failure—Sorafenib—thyroid cancer	0.000933	0.00669	CcSEcCtD
Pioglitazone—Urinary tract disorder—Vandetanib—thyroid cancer	0.000922	0.00662	CcSEcCtD
Pioglitazone—Urethral disorder—Vandetanib—thyroid cancer	0.000916	0.00657	CcSEcCtD
Pioglitazone—Pain in extremity—Sorafenib—thyroid cancer	0.000911	0.00653	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000907	0.0286	CbGpPWpGaD
Pioglitazone—Visual impairment—Vandetanib—thyroid cancer	0.0009	0.00646	CcSEcCtD
Pioglitazone—Eye disorder—Vandetanib—thyroid cancer	0.000873	0.00626	CcSEcCtD
Pioglitazone—Cardiac disorder—Vandetanib—thyroid cancer	0.000867	0.00622	CcSEcCtD
Pioglitazone—Mediastinal disorder—Vandetanib—thyroid cancer	0.000842	0.00604	CcSEcCtD
Pioglitazone—Abdominal pain upper—Sorafenib—thyroid cancer	0.000832	0.00597	CcSEcCtD
Pioglitazone—Breast disorder—Sorafenib—thyroid cancer	0.000823	0.0059	CcSEcCtD
Pioglitazone—Malnutrition—Vandetanib—thyroid cancer	0.000813	0.00583	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.000803	0.00576	CcSEcCtD
Pioglitazone—Muscle spasms—Vandetanib—thyroid cancer	0.000782	0.00561	CcSEcCtD
Pioglitazone—Generalised oedema—Epirubicin—thyroid cancer	0.000779	0.00559	CcSEcCtD
Pioglitazone—SLCO1B1—Recycling of bile acids and salts—RXRA—thyroid cancer	0.000767	0.0242	CbGpPWpGaD
Pioglitazone—Polyp—Epirubicin—thyroid cancer	0.000762	0.00547	CcSEcCtD
Pioglitazone—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000759	0.024	CbGpPWpGaD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.000755	0.0238	CbGpPWpGaD
Pioglitazone—Erectile dysfunction—Sorafenib—thyroid cancer	0.000725	0.0052	CcSEcCtD
Pioglitazone—Generalised oedema—Doxorubicin—thyroid cancer	0.000721	0.00517	CcSEcCtD
Pioglitazone—Weight decreased—Sorafenib—thyroid cancer	0.000712	0.00511	CcSEcCtD
Pioglitazone—Polyp—Doxorubicin—thyroid cancer	0.000705	0.00506	CcSEcCtD
Pioglitazone—Hypertension—Vandetanib—thyroid cancer	0.000702	0.00504	CcSEcCtD
Pioglitazone—Infestation—Sorafenib—thyroid cancer	0.000702	0.00503	CcSEcCtD
Pioglitazone—Infestation NOS—Sorafenib—thyroid cancer	0.000702	0.00503	CcSEcCtD
Pioglitazone—Cyst—Epirubicin—thyroid cancer	0.000694	0.00498	CcSEcCtD
Pioglitazone—Chest pain—Vandetanib—thyroid cancer	0.000692	0.00497	CcSEcCtD
Pioglitazone—Arthralgia—Vandetanib—thyroid cancer	0.000692	0.00497	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000692	0.00496	CcSEcCtD
Pioglitazone—Myocardial infarction—Sorafenib—thyroid cancer	0.000688	0.00494	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000687	0.00493	CcSEcCtD
Pioglitazone—Oedema—Vandetanib—thyroid cancer	0.000664	0.00476	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.000661	0.0208	CbGpPWpGaD
Pioglitazone—Infection—Vandetanib—thyroid cancer	0.000659	0.00473	CcSEcCtD
Pioglitazone—Nervous system disorder—Vandetanib—thyroid cancer	0.000651	0.00467	CcSEcCtD
Pioglitazone—Skin disorder—Vandetanib—thyroid cancer	0.000644	0.00462	CcSEcCtD
Pioglitazone—Cyst—Doxorubicin—thyroid cancer	0.000642	0.0046	CcSEcCtD
Pioglitazone—Urinary tract disorder—Sorafenib—thyroid cancer	0.000622	0.00446	CcSEcCtD
Pioglitazone—Connective tissue disorder—Sorafenib—thyroid cancer	0.000619	0.00444	CcSEcCtD
Pioglitazone—Urethral disorder—Sorafenib—thyroid cancer	0.000618	0.00443	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000605	0.00434	CcSEcCtD
Pioglitazone—Insomnia—Vandetanib—thyroid cancer	0.0006	0.00431	CcSEcCtD
Pioglitazone—SLCO1B3—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000597	0.0188	CbGpPWpGaD
Pioglitazone—Dyspnoea—Vandetanib—thyroid cancer	0.000592	0.00424	CcSEcCtD
Pioglitazone—Cardiac disorder—Sorafenib—thyroid cancer	0.000585	0.00419	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000573	0.00411	CcSEcCtD
Pioglitazone—Glycosuria—Epirubicin—thyroid cancer	0.000572	0.00411	CcSEcCtD
Pioglitazone—Fatigue—Vandetanib—thyroid cancer	0.000572	0.0041	CcSEcCtD
Pioglitazone—Immune system disorder—Sorafenib—thyroid cancer	0.000569	0.00408	CcSEcCtD
Pioglitazone—Mediastinal disorder—Sorafenib—thyroid cancer	0.000568	0.00407	CcSEcCtD
Pioglitazone—Malnutrition—Sorafenib—thyroid cancer	0.000548	0.00393	CcSEcCtD
Pioglitazone—Glycosuria—Doxorubicin—thyroid cancer	0.00053	0.0038	CcSEcCtD
Pioglitazone—Muscle spasms—Sorafenib—thyroid cancer	0.000527	0.00378	CcSEcCtD
Pioglitazone—Anaemia—Sorafenib—thyroid cancer	0.000507	0.00364	CcSEcCtD
Pioglitazone—Angioedema—Sorafenib—thyroid cancer	0.000501	0.0036	CcSEcCtD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00049	0.0155	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—RXRA—thyroid cancer	0.000488	0.0154	CbGpPWpGaD
Pioglitazone—Asthenia—Vandetanib—thyroid cancer	0.000476	0.00342	CcSEcCtD
Pioglitazone—Hypertension—Sorafenib—thyroid cancer	0.000473	0.0034	CcSEcCtD
Pioglitazone—Arthralgia—Sorafenib—thyroid cancer	0.000467	0.00335	CcSEcCtD
Pioglitazone—Myalgia—Sorafenib—thyroid cancer	0.000467	0.00335	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000464	0.00333	CcSEcCtD
Pioglitazone—Diarrhoea—Vandetanib—thyroid cancer	0.000454	0.00326	CcSEcCtD
Pioglitazone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000448	0.00321	CcSEcCtD
Pioglitazone—Infection—Sorafenib—thyroid cancer	0.000445	0.00319	CcSEcCtD
Pioglitazone—Fluid retention—Epirubicin—thyroid cancer	0.00044	0.00316	CcSEcCtD
Pioglitazone—Nervous system disorder—Sorafenib—thyroid cancer	0.000439	0.00315	CcSEcCtD
Pioglitazone—Dizziness—Vandetanib—thyroid cancer	0.000439	0.00315	CcSEcCtD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000438	0.0138	CbGpPWpGaD
Pioglitazone—Skin disorder—Sorafenib—thyroid cancer	0.000435	0.00312	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000426	0.00306	CcSEcCtD
Pioglitazone—Neoplasm—Epirubicin—thyroid cancer	0.000419	0.00301	CcSEcCtD
Pioglitazone—Headache—Vandetanib—thyroid cancer	0.000416	0.00298	CcSEcCtD
Pioglitazone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000413	0.00296	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000408	0.00293	CcSEcCtD
Pioglitazone—Fluid retention—Doxorubicin—thyroid cancer	0.000407	0.00292	CcSEcCtD
Pioglitazone—Abnormal vision—Epirubicin—thyroid cancer	0.000404	0.0029	CcSEcCtD
Pioglitazone—SLCO1B1—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000401	0.0127	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000399	0.0126	CbGpPWpGaD
Pioglitazone—Dyspnoea—Sorafenib—thyroid cancer	0.000399	0.00286	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000394	0.00283	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—thyroid cancer	0.000388	0.00278	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—thyroid cancer	0.000387	0.00278	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000386	0.00277	CcSEcCtD
Pioglitazone—Fatigue—Sorafenib—thyroid cancer	0.000386	0.00277	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000385	0.0122	CbGpPWpGaD
Pioglitazone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000382	0.00274	CcSEcCtD
Pioglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.000377	0.0119	CbGpPWpGaD
Pioglitazone—Hepatic failure—Epirubicin—thyroid cancer	0.000375	0.00269	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—thyroid cancer	0.000374	0.00268	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000371	0.00266	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—thyroid cancer	0.000358	0.00257	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000358	0.00257	CcSEcCtD
Pioglitazone—Urticaria—Sorafenib—thyroid cancer	0.000356	0.00255	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—thyroid cancer	0.000347	0.00249	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—thyroid cancer	0.000345	0.00247	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—thyroid cancer	0.000345	0.00247	CcSEcCtD
Pioglitazone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000345	0.0109	CbGpPWpGaD
Pioglitazone—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000343	0.00246	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000343	0.00246	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—thyroid cancer	0.000337	0.00241	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—thyroid cancer	0.000331	0.00238	CcSEcCtD
Pioglitazone—Hypersensitivity—Sorafenib—thyroid cancer	0.00033	0.00237	CcSEcCtD
Pioglitazone—Asthenia—Sorafenib—thyroid cancer	0.000321	0.0023	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—thyroid cancer	0.000319	0.00229	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000319	0.00229	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000318	0.00228	CcSEcCtD
Pioglitazone—PPARG—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000317	0.01	CbGpPWpGaD
Pioglitazone—Pain in extremity—Doxorubicin—thyroid cancer	0.000311	0.00223	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—thyroid cancer	0.000311	0.00223	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—thyroid cancer	0.000307	0.00221	CcSEcCtD
Pioglitazone—Diarrhoea—Sorafenib—thyroid cancer	0.000306	0.0022	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—thyroid cancer	0.000304	0.00218	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000297	0.00213	CcSEcCtD
Pioglitazone—Dizziness—Sorafenib—thyroid cancer	0.000296	0.00212	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000295	0.00932	CbGpPWpGaD
Pioglitazone—Influenza—Epirubicin—thyroid cancer	0.000291	0.00209	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000288	0.00206	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000284	0.00204	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—thyroid cancer	0.000283	0.00203	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—thyroid cancer	0.000281	0.00202	CcSEcCtD
Pioglitazone—Headache—Sorafenib—thyroid cancer	0.00028	0.00201	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—thyroid cancer	0.00028	0.00201	CcSEcCtD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—thyroid cancer	0.000277	0.00875	CbGpPWpGaD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000275	0.00197	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00027	0.00194	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—thyroid cancer	0.000269	0.00193	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—thyroid cancer	0.000265	0.0019	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—thyroid cancer	0.000263	0.00189	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000262	0.00188	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—thyroid cancer	0.000262	0.00188	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—thyroid cancer	0.000259	0.00186	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—thyroid cancer	0.000259	0.00186	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—thyroid cancer	0.000259	0.00186	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—thyroid cancer	0.000252	0.00181	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00025	0.00179	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—thyroid cancer	0.000249	0.00178	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—thyroid cancer	0.000247	0.00177	CcSEcCtD
Pioglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000245	0.00773	CbGpPWpGaD
Pioglitazone—Weight increased—Doxorubicin—thyroid cancer	0.000245	0.00176	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—thyroid cancer	0.000244	0.00175	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—thyroid cancer	0.000243	0.00175	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000243	0.00174	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—thyroid cancer	0.00024	0.00172	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—thyroid cancer	0.00024	0.00172	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000233	0.00167	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—thyroid cancer	0.000233	0.00167	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000232	0.00166	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—thyroid cancer	0.000231	0.00166	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—thyroid cancer	0.00023	0.00165	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—thyroid cancer	0.00023	0.00165	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—thyroid cancer	0.000229	0.00165	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—thyroid cancer	0.000229	0.00164	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000229	0.00164	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—thyroid cancer	0.000228	0.00164	CcSEcCtD
Pioglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000226	0.00713	CbGpPWpGaD
Pioglitazone—Sinusitis—Doxorubicin—thyroid cancer	0.000225	0.00162	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—thyroid cancer	0.000224	0.00161	CcSEcCtD
Pioglitazone—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000223	0.00705	CbGpPWpGaD
Pioglitazone—Eye disorder—Epirubicin—thyroid cancer	0.000218	0.00156	CcSEcCtD
Pioglitazone—PPARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000217	0.00684	CbGpPWpGaD
Pioglitazone—Cardiac disorder—Epirubicin—thyroid cancer	0.000216	0.00155	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—thyroid cancer	0.000215	0.00155	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000214	0.00154	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—thyroid cancer	0.000214	0.00153	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000213	0.00153	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000212	0.00152	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000212	0.00152	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—thyroid cancer	0.000211	0.00152	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—thyroid cancer	0.00021	0.00151	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—thyroid cancer	0.00021	0.00151	CcSEcCtD
Pioglitazone—PPARG—PPARA activates gene expression—RXRA—thyroid cancer	0.000208	0.00658	CbGpPWpGaD
Pioglitazone—Visual impairment—Doxorubicin—thyroid cancer	0.000208	0.00149	CcSEcCtD
Pioglitazone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000206	0.00651	CbGpPWpGaD
Pioglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000206	0.0065	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000205	0.00647	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000204	0.00644	CbGpPWpGaD
Pioglitazone—Malnutrition—Epirubicin—thyroid cancer	0.000203	0.00145	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—thyroid cancer	0.000201	0.00144	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—thyroid cancer	0.0002	0.00143	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—thyroid cancer	0.0002	0.00143	CcSEcCtD
Pioglitazone—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000199	0.00629	CbGpPWpGaD
Pioglitazone—Back pain—Epirubicin—thyroid cancer	0.000196	0.00141	CcSEcCtD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000195	0.00616	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000195	0.00616	CbGpPWpGaD
Pioglitazone—Muscle spasms—Epirubicin—thyroid cancer	0.000195	0.0014	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—thyroid cancer	0.000195	0.0014	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—thyroid cancer	0.000194	0.00614	CbGpPWpGaD
Pioglitazone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000194	0.00139	CcSEcCtD
Pioglitazone—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000192	0.00606	CbGpPWpGaD
Pioglitazone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000188	0.00135	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—thyroid cancer	0.000188	0.00135	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—thyroid cancer	0.000187	0.00134	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—thyroid cancer	0.000185	0.00133	CcSEcCtD
Pioglitazone—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000183	0.00579	CbGpPWpGaD
Pioglitazone—Malaise—Epirubicin—thyroid cancer	0.000183	0.00131	CcSEcCtD
Pioglitazone—PPARG—Adipogenesis—RXRA—thyroid cancer	0.000182	0.00575	CbGpPWpGaD
Pioglitazone—Vertigo—Epirubicin—thyroid cancer	0.000182	0.00131	CcSEcCtD
Pioglitazone—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000182	0.00574	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000182	0.00573	CbGpPWpGaD
Pioglitazone—Back pain—Doxorubicin—thyroid cancer	0.000181	0.0013	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—thyroid cancer	0.00018	0.00129	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—thyroid cancer	0.000175	0.00126	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000174	0.00125	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—thyroid cancer	0.000173	0.00124	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—thyroid cancer	0.000173	0.00124	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—thyroid cancer	0.000173	0.00124	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—thyroid cancer	0.000173	0.00124	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000171	0.00123	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—thyroid cancer	0.00017	0.00122	CcSEcCtD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—CCND1—thyroid cancer	0.00017	0.00537	CbGpPWpGaD
Pioglitazone—Malaise—Doxorubicin—thyroid cancer	0.000169	0.00121	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—thyroid cancer	0.000168	0.00121	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—thyroid cancer	0.000165	0.00119	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000165	0.00119	CcSEcCtD
Pioglitazone—Infection—Epirubicin—thyroid cancer	0.000164	0.00118	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—thyroid cancer	0.000162	0.00116	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—thyroid cancer	0.000162	0.00116	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—thyroid cancer	0.000161	0.00115	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—thyroid cancer	0.00016	0.00115	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—thyroid cancer	0.00016	0.00115	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—thyroid cancer	0.00016	0.00115	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—thyroid cancer	0.00016	0.00115	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000159	0.00114	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—thyroid cancer	0.000158	0.00113	CcSEcCtD
Pioglitazone—PPARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000157	0.00494	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000155	0.00489	CbGpPWpGaD
Pioglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000153	0.00483	CbGpPWpGaD
Pioglitazone—Oedema—Doxorubicin—thyroid cancer	0.000153	0.0011	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000153	0.0011	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—thyroid cancer	0.000152	0.00109	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000151	0.00108	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—thyroid cancer	0.00015	0.00108	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—thyroid cancer	0.00015	0.00107	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—thyroid cancer	0.000149	0.00107	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000148	0.00106	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—thyroid cancer	0.000147	0.00106	CcSEcCtD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000146	0.00461	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000143	0.00102	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—thyroid cancer	0.000143	0.00102	CcSEcCtD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000141	0.00444	CbGpPWpGaD
Pioglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000141	0.00443	CbGpPWpGaD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000139	0.001	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—thyroid cancer	0.000138	0.000993	CcSEcCtD
Pioglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000137	0.00431	CbGpPWpGaD
Pioglitazone—Dyspnoea—Doxorubicin—thyroid cancer	0.000136	0.000979	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—thyroid cancer	0.000136	0.000978	CcSEcCtD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000136	0.0043	CbGpPWpGaD
Pioglitazone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000136	0.00429	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—HIF1A—thyroid cancer	0.000135	0.00427	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000132	0.000948	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—thyroid cancer	0.000132	0.000947	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—thyroid cancer	0.000131	0.000943	CcSEcCtD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000131	0.00414	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000131	0.00414	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000126	0.000905	CcSEcCtD
Pioglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000126	0.00397	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—MINPP1—thyroid cancer	0.000125	0.00396	CbGpPWpGaD
Pioglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000125	0.00393	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000124	0.00392	CbGpPWpGaD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000124	0.00391	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000122	0.00385	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Epirubicin—thyroid cancer	0.000122	0.000874	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—thyroid cancer	0.000122	0.000872	CcSEcCtD
Pioglitazone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.00012	0.00378	CbGpPWpGaD
Pioglitazone—Asthenia—Epirubicin—thyroid cancer	0.000119	0.000851	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—thyroid cancer	0.000113	0.000812	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000113	0.000809	CcSEcCtD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000111	0.0035	CbGpPWpGaD
Pioglitazone—Asthenia—Doxorubicin—thyroid cancer	0.00011	0.000788	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—thyroid cancer	0.000109	0.000785	CcSEcCtD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000109	0.00342	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—MINPP1—thyroid cancer	0.000107	0.00338	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	0.000107	0.00337	CbGpPWpGaD
Pioglitazone—Diarrhoea—Doxorubicin—thyroid cancer	0.000105	0.000751	CcSEcCtD
Pioglitazone—PPARG—Gene Expression—TRIM33—thyroid cancer	0.000104	0.00329	CbGpPWpGaD
Pioglitazone—Headache—Epirubicin—thyroid cancer	0.000104	0.000743	CcSEcCtD
Pioglitazone—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000102	0.00322	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000102	0.00322	CbGpPWpGaD
Pioglitazone—Dizziness—Doxorubicin—thyroid cancer	0.000101	0.000726	CcSEcCtD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000101	0.00319	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CHST14—thyroid cancer	0.0001	0.00317	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	9.95e-05	0.00314	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	9.91e-05	0.00313	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	9.91e-05	0.00313	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	9.81e-05	0.0031	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.75e-05	0.00308	CbGpPWpGaD
Pioglitazone—Headache—Doxorubicin—thyroid cancer	9.59e-05	0.000688	CcSEcCtD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	9.47e-05	0.00299	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NDUFA13—thyroid cancer	9.1e-05	0.00287	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.8e-05	0.00278	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	8.67e-05	0.00274	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CHST14—thyroid cancer	8.56e-05	0.0027	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MINPP1—thyroid cancer	8.43e-05	0.00266	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.22e-05	0.00259	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.17e-05	0.00258	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—HPGD—thyroid cancer	8.09e-05	0.00255	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.85e-05	0.00248	CbGpPWpGaD
Pioglitazone—PPARG—SREBP signalling—AKT1—thyroid cancer	7.55e-05	0.00238	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—THRB—thyroid cancer	7.54e-05	0.00238	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MINPP1—thyroid cancer	7.5e-05	0.00237	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.42e-05	0.00234	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	7.17e-05	0.00226	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.16e-05	0.00226	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.01e-05	0.00221	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—HPGD—thyroid cancer	6.9e-05	0.00218	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CDK1—thyroid cancer	6.75e-05	0.00213	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CHST14—thyroid cancer	6.74e-05	0.00213	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.66e-05	0.0021	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	6.66e-05	0.0021	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.66e-05	0.0021	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	6.66e-05	0.0021	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	6.59e-05	0.00208	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.56e-05	0.00207	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.55e-05	0.00207	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NDUFA13—thyroid cancer	6.38e-05	0.00201	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—RXRA—thyroid cancer	6.27e-05	0.00198	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.26e-05	0.00197	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.24e-05	0.00197	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CHST14—thyroid cancer	6e-05	0.00189	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.89e-05	0.00186	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.7e-05	0.0018	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.6e-05	0.00177	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	5.57e-05	0.00176	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—HPGD—thyroid cancer	5.43e-05	0.00171	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.41e-05	0.00171	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.37e-05	0.00169	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—TPR—thyroid cancer	5.1e-05	0.00161	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.99e-05	0.00157	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.84e-05	0.00153	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—HPGD—thyroid cancer	4.83e-05	0.00153	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MEN1—thyroid cancer	4.79e-05	0.00151	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TPR—thyroid cancer	4.64e-05	0.00147	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	4.57e-05	0.00144	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.41e-05	0.00139	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.32e-05	0.00136	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.19e-05	0.00132	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.14e-05	0.00131	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.12e-05	0.0013	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.98e-05	0.00126	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TPR—thyroid cancer	3.96e-05	0.00125	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.94e-05	0.00124	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.92e-05	0.00124	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PRKAR1A—thyroid cancer	3.9e-05	0.00123	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CHST14—thyroid cancer	3.87e-05	0.00122	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—thyroid cancer	3.8e-05	0.0012	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.68e-05	0.00116	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.54e-05	0.00112	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	3.48e-05	0.0011	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CHST14—thyroid cancer	3.46e-05	0.00109	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.38e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.35e-05	0.00106	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.26e-05	0.00103	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—RXRA—thyroid cancer	3.2e-05	0.00101	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CHST14—thyroid cancer	3.18e-05	0.001	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CHST14—thyroid cancer	3.15e-05	0.000995	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HPGD—thyroid cancer	3.12e-05	0.000985	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TPR—thyroid cancer	3.12e-05	0.000985	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.07e-05	0.000969	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SLC5A5—thyroid cancer	2.97e-05	0.000936	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RXRA—thyroid cancer	2.92e-05	0.000922	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.84e-05	0.000896	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HPGD—thyroid cancer	2.79e-05	0.000879	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.78e-05	0.000878	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.78e-05	0.000877	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TPR—thyroid cancer	2.78e-05	0.000876	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PRKAR1A—thyroid cancer	2.73e-05	0.000862	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.6e-05	0.000821	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HPGD—thyroid cancer	2.56e-05	0.000809	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HPGD—thyroid cancer	2.54e-05	0.000802	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.53e-05	0.000799	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RXRA—thyroid cancer	2.49e-05	0.000786	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.47e-05	0.000781	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.42e-05	0.000765	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—NRAS—thyroid cancer	2.42e-05	0.000764	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.34e-05	0.000737	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.26e-05	0.000713	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.21e-05	0.000698	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.19e-05	0.000691	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—thyroid cancer	2.08e-05	0.000658	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CHST14—thyroid cancer	2.08e-05	0.000656	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC5A5—thyroid cancer	2.08e-05	0.000656	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.06e-05	0.00065	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RXRA—thyroid cancer	1.96e-05	0.000619	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.95e-05	0.000614	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.91e-05	0.000602	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPARG—thyroid cancer	1.84e-05	0.000582	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TPR—thyroid cancer	1.79e-05	0.000566	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—thyroid cancer	1.77e-05	0.000559	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.76e-05	0.000557	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RXRA—thyroid cancer	1.75e-05	0.000551	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.7e-05	0.000536	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.68e-05	0.000529	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TPR—thyroid cancer	1.6e-05	0.000505	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.6e-05	0.000505	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.57e-05	0.000497	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—thyroid cancer	1.56e-05	0.000494	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TPR—thyroid cancer	1.47e-05	0.000464	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TPR—thyroid cancer	1.46e-05	0.00046	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.45e-05	0.000458	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.000457	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.44e-05	0.000453	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.43e-05	0.00045	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000424	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.3e-05	0.000411	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.27e-05	0.000399	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.26e-05	0.000397	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.24e-05	0.000391	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—thyroid cancer	1.24e-05	0.000391	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000378	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000356	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.12e-05	0.000354	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000348	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.1e-05	0.000348	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000346	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000345	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—thyroid cancer	1.08e-05	0.000341	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.02e-05	0.000323	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000318	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.79e-06	0.000309	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—thyroid cancer	9.75e-06	0.000308	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TPR—thyroid cancer	9.62e-06	0.000304	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	9.47e-06	0.000299	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RXRA—thyroid cancer	9.26e-06	0.000292	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RXRA—thyroid cancer	9.18e-06	0.00029	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.93e-06	0.000282	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—thyroid cancer	8.67e-06	0.000274	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—thyroid cancer	8.5e-06	0.000268	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—thyroid cancer	8e-06	0.000252	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—thyroid cancer	7.56e-06	0.000239	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—thyroid cancer	7.29e-06	0.00023	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.2e-06	0.000227	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—thyroid cancer	7.12e-06	0.000225	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—thyroid cancer	6.35e-06	0.000201	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—thyroid cancer	6.22e-06	0.000196	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RXRA—thyroid cancer	6.05e-06	0.000191	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—thyroid cancer	5.85e-06	0.000184	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—thyroid cancer	5.79e-06	0.000183	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.6e-06	0.000177	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—thyroid cancer	5e-06	0.000158	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—thyroid cancer	4.9e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—thyroid cancer	4.88e-06	0.000154	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.6e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.56e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—thyroid cancer	4.36e-06	0.000138	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—thyroid cancer	4.36e-06	0.000138	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—thyroid cancer	4.01e-06	0.000127	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—thyroid cancer	3.98e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—thyroid cancer	3.82e-06	0.000121	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.01e-06	9.49e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—thyroid cancer	2.81e-06	8.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—thyroid cancer	2.62e-06	8.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—thyroid cancer	2.51e-06	7.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—thyroid cancer	2.31e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—thyroid cancer	2.29e-06	7.23e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.51e-06	4.77e-05	CbGpPWpGaD
